## Abstract Ribonuclease A (RNase A) with several high affinity binding sites is a possible target for many organic and inorganic molecules. 3β²βAzidoβ3β²βdeoxythymidine (AZT) is the first clinically effective drug for the treatment of human immunodeficiency virus (HIV) infection. The drug interactio
Fluorescence Assay for the Binding of Ribonuclease A to the Ribonuclease Inhibitor Protein
β Scribed by Richele L. Abel; Marcia C. Haigis; Chiwook Park; Ronald T. Raines
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 222 KB
- Volume
- 306
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
β¦ Synopsis
Ribonuclease A (RNase A) and the ribonuclease inhibitor protein (RI) form one of the tightest known protein-protein complexes. RNase A variants and homologues, such as G88R RNase A, that retain ribonucleolytic activity in the presence of RI are toxic to cancer cells. Herein, a new and facile assay is described for measuring the equilibrium dissociation constant (K d ) and dissociation rate constant (k d ) for complexes of RI and RNase A. This assay is based on the decrease in fluorescence intensity that occurs when a fluorescein-labeled RNase A binds to RI. To allow time for equilibration, the assay is most readily applied to those complexes with K d values in the nanomolar range or higher. Using this assay, the value of K d for the complex of RI with fluorescein-labeled G88R RNase A was determined to be 0.55 Ψ 0.03 nM. In addition, the value of K d was determined for the complex of RI with unlabeled G88R RNase A to be 0.57 Ψ 0.05 nM by using a competition assay with fluorescein-labeled G88R RNase A. Finally, the value of k d for the complex of RI with fluorescein-labeled G88R RNase A was determined to be (7.5 Ψ 0.4) Ψ 10 Ψ3 s Ψ1 by monitoring the increase in fluorescence intensity upon dissociation. This assay can be used to characterize complexes of RI with a wide variety of RNase A variants and homologues, including those with cytotoxic activity.
π SIMILAR VOLUMES
Improper function of the tumor suppressor protein p53 is a contributing factor in many human cancers. In normal cells, p53 acts to arrest the cell cycle in response to DNA damage or nucleotide depletion. One mechanism of regulating the amount of p53 in the cell is through the action of the Double Mi
## Abstract Ribonuclease A is the archetype of a functionally diverse superfamily of vertebrateβspecific ribonucleases. Inhibitors of its action have potential use in the elucidation of the in vivo roles of these enzymes and in the treatment of pathologies associated therewith. Derivatives of adeno
A sensitive fluorescence resonance energy transfer method was developed for the direct measurement of the dissociation constants of stromelysin inhibitors. The method is applied to the thiadiazole class of stromelysin inhibitors and it takes advantage of the fact that, upon binding to the active sit